FDA official who approved OxyContin got $400,000 gig at Purdue Pharma a year later
GOVERNMENT OFFICIAL FOR SALE — May 2, 2021 - Purdue Pharma's sale of OxyContin, a formulation of the narcotic oxycodone that was said to slow down the release of the strong painkiller when taken as prescribed, h... Read More...